Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 545
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04220528 | Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC | ||
| NCT04319471 | Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma | ||
| NCT06366997 | Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test | ||
| NCT05420480 | Two-field Versus Three-field Lymph Node Dissection in ESCC After Neoadjuvant Therapy | ||
| NCT05206890 | A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian Cancer | ||
| NCT05126160 | Immune Score Based Radiomics in Nasopharyngeal Carcinoma | ||
| NCT06031597 | Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy | ||
| NCT05053386 | Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma | ||
| NCT03357094 | Pulmonary Ventilation/Perfusion Imaging for the Prediction of Postoperative Residual Pulmonary Function | ||
| NCT07002346 | INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma | ||
| NCT03520439 | Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis | ||
| NCT04981665 | A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection | ||
| NCT05705583 | A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immunotherapy in Renal Cell Carcinoma | ||
| NCT06303583 | Neoadjuvant Chemoradiotherapy Followed by Sequential Immunotherapy for Thoracic Esophageal Squamous Cell Carcinoma | ||
| NCT06383494 | GMA-Tulip, I-gel and the LMA-Supreme (LMA-S) Devices in Airway Management (GLAM-I) | ||
| NCT05124704 | Propofol EC50 for Inducing Loss of Consciousness in General Combined Epidural Anesthesia | ||
| NCT05544149 | TRT for ES-SCLC After First Line Treatment With Immune Checkpoint Inhibitors | ||
| NCT05322499 | Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer | ||
| NCT06863506 | Phase II Clinical Study of Befotertinib in EGFR Non-classical Mutant NSCLC | ||
| NCT04843215 | A Phase III Study Comparing Total and Partial Omentectomy for Patients With Advanced Gastric Cancer | ||
| NCT04850027 | MRI-guided Lateral Lymph Node Dissection in Rectal Cancer | ||
| NCT01918241 | Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia | ||
| NCT07175207 | Study on Safety and Efficacy of UCB-MNCs for Chronic Radiation Enteritis | ||
| NCT04436965 | Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition | ||
| NCT06832228 | Study of Pomalidomide Combination with Rituximab and Anti-PD-1 Antibody （PPR） in Third or Later Line Therapy of DLBCL | ||
| NCT04049344 | Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma | ||
| NCT02878889 | A Phase II Trial of S-1 as Maintenance Treatment After Gemcitabine Plus Cisplatin Regimen Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma. | ||
| NCT04446091 | A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC) | ||
| NCT03647527 | Predictor Analysis of Acute Radiation Oral Mucositis in NPC Patients Treated With IMRT/TOMO Combined Chemotherapy | ||
| NCT04506138 | Camrelizumab in Combination With Neoadjuvant Chemotherapy for Resectable Thoracic Esophageal Squamous Cell Carcinoma | ||
| NCT02487316 | A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib | ||
| NCT03637634 | The Children and Adolescents Nasopharyngeal Carcinoma Survivor Study | ||
| NCT01398449 | Is ENI Necessary For Patients With Thoracic Esophageal Cancer After Esophagectomy And With Pathological Stage Of T1-2,N+,M0 | ||
| NCT07691515 | Intraarterial Therapies Plus Tislelizumab Plus Lenvatinib Versus Tislelizumab Plus Gemcitabine-Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma | ||
| NCT05269056 | Early Detection of Gastric Cancer Using Plasma Cell-free DNA Fragmentomics | ||
| NCT06288360 | Neoadjuvant Immunochemotherapy in PD-L1-negative LACC | ||
| NCT06350162 | Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC | ||
| NCT07067983 | Clinical Evaluation of GRAPE Model for Gastric Cancer Screening | ||
| NCT03837782 | Outcome of Resection for Colorectal Cancer | ||
| NCT07486700 | The Phase I Study of SIG001 Antibody on Cancer Therapy. | ||
| NCT06383533 | Disitamab Vedotin Plus Cadonilimab in Patients With HER2 Mutant Advanced or Metastatic Bile Duct Adenocarcinoma | ||
| NCT03455023 | Individualized Pharmaceutical-care for Inpatients With Cancer Pain | ||
| NCT07702838 | Immunotherapy Combined With Carbon Ion Radiotherapy for Locally Advanced Cervical Cancer | ||
| NCT06911086 | SH-LPS System in Preoperative Planning for Liver Resection | ||
| NCT06863831 | A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC | ||
| NCT03829553 | Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment | ||
| NCT01514877 | Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer | ||
| NCT07441720 | Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT) | ||
| NCT07014410 | Pyrotinib Combined With Dalpiciclib Combined With Letrozole in ER-positive and HER2-positive Advanced Breast Cancer | ||
| NCT06272214 | Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy |
